Evolent Health Inc (NYSE:EVH) price on Wednesday, February 05, rose 1.17% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $10.37.
A look at the stock’s price movement, the close in the last trading session was $10.25, moving within a range at $10.16 and $10.54. The beta value (5-Year monthly) was 1.587. Turning to its 52-week performance, $35.00 and $9.74 were the 52-week high and 52-week low respectively. Overall, EVH moved -12.71% over the past month.
Evolent Health Inc’s market cap currently stands at around $1.21 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 651.01M for the company’s revenue for the quarter, with a low and high estimate of 635.37M and 666.54M respectively. The average forecast suggests up to a 17.08% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.56B, representing a 30.33% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that EVH is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend EVH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EVH’s current price about -3.05% and -7.67% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.84, while 7-day volatility ratio is 3.85% and 6.02% in the 30-day chart. Further, Evolent Health Inc (EVH) has a beta value of 1.47, and an average true range (ATR) of 0.59. Analysts have given the company’s stock an average 52-week price target of $19, forecast between a low of $14 and high of $38. Looking at the price targets, the low is -35.0% off current price level while to achieve the yearly target high, price needs to move -266.44%. Nonetheless, investors will most likely welcome a -83.22% jump to $19 which is the analysts’ median price.
If we refocus on Evolent Health Inc (NYSE:EVH), historical trading data shows that trading volumes averaged 1.66 over the past 10 days and 2.80 million over the past 3 months. The company’s latest data on shares outstanding shows there are 115.01 million shares.
The 3.25% of Evolent Health Inc’s shares are in the hands of company insiders while institutional holders own 110.44% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.29 million on 2025-01-15, giving us a short ratio of 5.2. The data shows that as of 2025-01-15 short interest in Evolent Health Inc (EVH) stood at 1118.99994 of shares outstanding, with shares short rising to 9.76 million registered in 2024-12-13. Current price change has pushed the stock -7.82% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EVH stock continues to rise going into the next quarter.
